home / stock / phio / phio news

PHIO News and Press, Phio Pharmaceuticals Corp. From 05/24/23

Stock Information
Company Name: Phio Pharmaceuticals Corp.
Stock Symbol: PHIO
Market: NASDAQ
Website: phiopharma.com
Menu
PHIO PHIO Quote PHIO Short PHIO News PHIO Articles PHIO Message Board
Get PHIO Alerts

News, Short Squeeze, Breakout and More Instantly...
PHIO - Phio stock rises ~12% as cancer drug trial set for patient enrollment

2023-05-24 09:54:18 ET Phio Pharmaceuticals ( NASDAQ: PHIO ) stock rose ~12% on Wednesday after the company said its clinical development partner AgonOx in collaboration with Providence Cancer Institute completed a site initiation visit and can start patient accrual. The t...
PHIO - Phio Pharmaceuticals Announces Initiation of Collaborative Clinical Trial with PH-762, AgonOx's Tumor Infiltrating Lymphocyte Program (AGX148) and Providence Cancer Institute

Phio Pharmaceuticals Announces Initiation of Collaborative Clinical Trial with PH-762, AgonOx's Tumor Infiltrating Lymphocyte Program (AGX148) and Providence Cancer Institute PR Newswire One of two newly announced clinical trials for its lead product candidate, PH-762 ...

PHIO - Lucy Scientific, Bioventus top healthcare gainers; Enveric, Elevation among losers

2023-05-19 10:04:48 ET Gainers: Lucy Scientific Discovery ( LSDI ) +51% . Bioventus ( BVS ) +44% . Mallinckrodt ( MNK ) +28% . 180 Life Sciences ( ATNF ) +28% . Stereotaxis ( STXS ) +25% . Losers: Enveric Biosciences ( ENVB ...

PHIO - TIO, PHIO and ALIM among pre-market losers

2023-05-19 08:20:32 ET Foot Locker FL -25% after Q1 earning release . Phio Pharmaceuticals ( PHIO ) -12% . Infobird ( IFBD ) -12% . Alimera Sciences ( ALIM ) -11% . Enveric Biosciences ( ENVB ) -10% . Eledon Pharmaceuticals ( E...
PHIO - PHIO, AVTX and JFU among mid-day movers

2023-05-18 12:42:08 ET Gainers: Enveric Biosciences ( ENVB ) +112% . Phio Pharmaceuticals ( PHIO ) +46% . WANG & LEE GROUP ( WLGS ) +34% . Alimera Sciences ( ALIM ) +29% . SciPlay Corporation ( SCPL ) +26% . Eltek ( ELT...

PHIO - Phio Pharmaceuticals Presents Preclinical Study Showing INTASYL(TM) Treatment of NK Cells More than Doubles Ability to Kill Tumor Cells

Phio Pharmaceuticals Presents Preclinical Study Showing INTASYL™ Treatment of NK Cells More than Doubles Ability to Kill Tumor Cells PR Newswire Data is being presented at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting MARLBOROUGH, Mas...

PHIO - XELA, ORMP and BNMV among mid-day movers

2023-05-16 13:08:04 ET Gainers: GD Culture Group Limited ( GDC ) +84% . The Singing Machine Company ( MICS ) +62% . Applied Digital Corporation ( APLD ) +51% . Exela Technologies ( XELA ) +40% . AN2 Therapeutics ( ANTX ) +26% . ...
PHIO - Phio, Coya top healthcare gainers; Eloxx, Modular Medical among losers

2023-05-16 10:07:34 ET Gainers: Phio Pharmaceuticals ( PHIO ) +30% . Coya Therapeutics ( COYA ) +23% . Nanobiotix ( NBTX ) +12% . Savara ( SVRA ) +12% . Bellerophon Therapeutics ( BLPH ) +11% . Losers: Eloxx Pharmaceutical...

PHIO - Phio Pharma's lead candidate, PH-762, receives FDA clearance for clinical trial, shares surge by 28%

2023-05-16 09:01:37 ET Phio Pharma ( NASDAQ: PHIO ) witnessed a significant premarket surge of 28% following its announcement that the U.S. Food and Drug Administration (FDA) had granted clearance for its Investigational New Drug ( IND ) application. This clearance pav...

PHIO - Phio Pharmaceuticals Announces FDA Clearance to Initiate Clinical Trial of PH-762 for Treatment of Skin Carcinomas

Phio Pharmaceuticals Announces FDA Clearance to Initiate Clinical Trial of PH-762 for Treatment of Skin Carcinomas PR Newswire MARLBOROUGH, Mass. , May 16, 2023 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company...
Previous 10 Next 10